fencamfamine
Bluelighter
- Joined
- Feb 26, 2011
- Messages
- 151
May I strongly recommend the paper
'Insights into subtype selectivity of opioid agonists by ligand-based and structure-based methods'
By
Jianxin Cheng & Guixia Liu & Jing Zhang & Zhejun Xu & Yun Tang
Journal of Molecular Modelling.
March 2011
Volume 17
Issue 3
Pages 477-93
PMID: 20499259
In it, they detail how they used Discover Studio 7 with training sets to outline the pharmocore of each of the receptors. In essence, they took around 20 potent DOR, KOR & MOR ligands to find common features. When you have this, it's possible to work out the active confirmation of any (potential) agonist or antagonist one may come across.
Of course, it doesn't begin to detail the effects of pLog, pKa, catabolism and other important factors. It is, however, a very good place to start.
'Insights into subtype selectivity of opioid agonists by ligand-based and structure-based methods'
By
Jianxin Cheng & Guixia Liu & Jing Zhang & Zhejun Xu & Yun Tang
Journal of Molecular Modelling.
March 2011
Volume 17
Issue 3
Pages 477-93
PMID: 20499259
In it, they detail how they used Discover Studio 7 with training sets to outline the pharmocore of each of the receptors. In essence, they took around 20 potent DOR, KOR & MOR ligands to find common features. When you have this, it's possible to work out the active confirmation of any (potential) agonist or antagonist one may come across.
Of course, it doesn't begin to detail the effects of pLog, pKa, catabolism and other important factors. It is, however, a very good place to start.
Last edited:
